Readers researching the broader hepatocyte growth factor / c-Met pathway for cognitive indications should be aware that Fosgonimeton (development code ATH-1017), a structurally distinct small-molecule prodrug developed by Athira Pharma as an HGF positive modulator, has been investigated in three clinical trials in dementia indications
The Protect also includes sulforaphane from broccoli seed extracta powerful compound known to activate the NRF2 pathway , the bodys master regulator of antioxidant and detoxification enzymes
The enhanced bioavailability of liposomal formulations may provide more consistent immune support, particularly beneficial for individuals with compromised glutathione production or increased oxidative stress exposure
Nencioni A, Caffa I, Cortellino S, Longo VD (2018) Fasting and cancer: molecular mechanisms and clinical application
VisiFree - 6 PackThere are two main types of treatments for age-related vision loss
You get access to drugs, devices, and disposables all in the same place
